Antimetabolite incorporation into DNA: Structural and thermodynamic basis for anticancer activity

被引:9
作者
Gmeiner, WH [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA
关键词
anticancer drugs; antipyrimidines; DNA-modifying proteins;
D O I
10.1002/bip.10214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antimetabolites are a class of effective anticancer drugs that structurally resemble naturally occurring biochemicals and interfere in essential biochemical processes. In this review, the recent literature describing investigations of the structural and thermodynamic basis for the anticancer activity of three antipyrimidines [1-beta-D-arabinofuranosyl cytidine (AraC). 2',2'-difluoro deoxycytidine (dFdC), and 5-fluoro-2'-deoxyuridine (FdUrd)] is summarized Our laboratory, and others, have shown that misincorporation of any of these three antipyrimidines into DNA perturbs the structure and decreases the stability of duplex DNA. These data are useful for rationalizing the, effects of antipyrimidine misincorporation on the activities of proteins required for DNA replication and repair such as DNA topoisomerase I and DNA polymerases. The studies completed to date and summarized in this review demonstrate the utility of investigations into the structure-function relationships between antipyrimidine-substituted DNA complexed with DNA-modifying proteins for the purpose of understanding the basis for effective antipyrimidine cancer chemotherapy and the future design of novel anticancer drugs. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:180 / 189
页数:10
相关论文
共 56 条
[31]   Targeted drug delivery to chemoresistant cells: Folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells [J].
Liu, JQ ;
Kolar, C ;
Lawson, TA ;
Gmeiner, WH .
JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (17) :5655-5663
[32]  
Longley DB, 2001, CLIN CANCER RES, V7, P3533
[33]   Recent advances in the use of radio sensitizing nucleosides [J].
McGinn, CJ ;
Lawrence, TS .
SEMINARS IN RADIATION ONCOLOGY, 2001, 11 (04) :270-280
[34]  
Meyers M, 2001, CANCER RES, V61, P5193
[35]  
Petak I, 2000, CLIN CANCER RES, V6, P4432
[36]  
PLAGEMANN PGW, 1978, CANCER RES, V38, P978
[37]  
Plunkett W, 1996, SEMIN ONCOL, V23, P3
[38]  
PLUNKETT W, 1995, SEMIN ONCOL, V22, P3
[39]   Induction of topoisomerase I cleavage complexes by 1-β-D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells [J].
Pourquier, P ;
Takebayashi, Y ;
Urasaki, Y ;
Gioffre, C ;
Kohlhagen, G ;
Pommier, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1885-1890
[40]   Topoisomerase I-mediated DNA damage [J].
Pourquier, P ;
Pommier, Y .
ADVANCES IN CANCER RESEARCH, VOL 80, 2001, 80 :189-216